Misregulation of gene expression in the redox‐sensitive NF‐κb‐dependent limb outgrowth pathway by thalidomide

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Developmental Dynamics

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1002/dvdy.10150PMID 12242718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemically Induced Birth Defects

  2002cited by this paper
• Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb.

  2002cited by this paper
• Some distal limb structures develop in mice lacking Sonic hedgehog signaling.

  2001cited by this paper
• Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses.

  2001cited by this paper
• Altered differentiation in rat and rabbit limb bud micromass cultures by glutathione modulating agents.

  2001cited by this paper
• Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.

  2000cited by this paper
• Integration of FGF and TWIST in calvarial bone and suture development.

  2000cited by this paper
• Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

  1999cited by this paper
• The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC.

  1999cited by this paper
• Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro.

  1999cited by this paper
• FGF-FGFR signaling in vertebrate organogenesis.

  1999cited by this paper
• Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations.

  1998influential reference
• Redox signals and NF-kappaB activation in T cells.

  1998cited by this paper
• Redox Signals and NF-κB Activation in T Cells

  1998cited by this paper
• The roles of FGFs in the early development of vertebrate limbs.

  1998cited by this paper
• Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis

  1998influential reference
• The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome.

  1998cited by this paper
• Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction.

  1998cited by this paper
• Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb

  1998cited by this paper
• The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor.

  1997influential reference
• Redox regulation of NF-kappa B activation.

  1997cited by this paper
• Redox regulation of transcriptional activators.

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• Roles for FGF8 in the induction, initiation, and maintenance of chick limb development.

  1996cited by this paper
• Antioxidant and redox regulation of gene transcription

  1996cited by this paper
• Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouse

  1996cited by this paper
• Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb.

  1996cited by this paper
• Regulation of the DNA binding activity of NF-kappa B.

  1995cited by this paper
• 軟骨無形成症のおける Fibroblast Growth Factor Receptor 遺伝子の解析

  1995cited by this paper
• Regulation of the DNA binding activity of NF-κB

  1995cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro.

  1994cited by this paper
• Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1.

  1994cited by this paper
• Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro

  1994cited by this paper
• Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.

  1993cited by this paper
• Wholemount in situ hybridization of vertebrate embryos

  1992cited by this paper
• Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.

  1992cited by this paper
• Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62

  1992cited by this paper
• Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence.

  1991cited by this paper
• Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.

  1991cited by this paper
• Testing of retinoids for teratogenicity in vitro: use of micromass limb bud cell culture.

  1990cited by this paper
• The Biochemical Basis of Chemical Teratogenesis

  1982cited by this paper
• A quantitative analysis of the effect of excision of the AER from the chick limb-bud.

  1974cited by this paper

• Thalidomide-induced limb malformations: an update and reevaluation

  2025cites this paper
• The effect of enantiomers of thalidomide on colon cells-Raman spectroscopy studies.

  2025cites this paper
• Congenital Single Digit Deformities: Series of Cases in Multiple Families in Remote Villages of Haryana

  2024cites this paper
• Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis

  2023cites this paper
• Real-time analysis of dynamic compartmentalized GSH redox shifts and H2O2 availability in undifferentiated and differentiated cells.

  2023cites this paper
• Thalidomide upper limb embryopathy – pathogenesis, past and present management and future considerations

  2023cites this paper
• Thalidomide: The journey from curse to boon

  2023cites this paper
• A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide

  2020cites this paper
• Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients

  2020cites this paper
• Molecular Mechanisms of the Teratogenic Effects of Thalidomide

  2020cites this paper
• Molecular mechanisms of thalidomide and its derivatives

  2020cites this paper
• The Redox Theory of Development

  2019cites this paper
• Rat Whole Embryo Culture.

  2019cites this paper
• Molecular Mechanisms of Thalidomide-induced Limb Malformations

  2019cites this paper
• Genetic susceptibility to thalidomide embryopathy in humans: Study of candidate development genes.

  2018cites this paper
• Oxidative stress during development: Chemical-induced teratogenesis

  2018cites this paper
• Structural basis of thalidomide enantiomer binding to cereblon

  2018cites this paper
• Whole Mount In Situ Hybridization and Morphometric Analysis in Rabbit Embryos.

  2018cites this paper
• Redox stress and signaling during vertebrate embryonic development: Regulation and responses.

  2017cites this paper
• Significance of the antiangiogenic mechanisms of thalidomide in the therapy of diabetic retinopathy.

  2017cites this paper
• Valproic acid increases NF-κB transcriptional activation despite decreasing DNA binding ability in P19 cells, which may play a role in VPA-initiated teratogenesis.

  2017cites this paper
• The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.

  2017cites this paper
• Chapter 26 – Thalidomide

  2017cites this paper
• Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.

  2016cites this paper
• Genetic Advances in the Understanding of Microtia

  2016cites this paper
• Mono-2-ethylhexyl phthalate disrupts neurulation and modifies the embryonic redox environment and gene expression.

  2016cites this paper
• Glutathione during embryonic development.

  2015cites this paper
• Thalidomide‐induced teratogenesis: History and mechanisms

  2015influential citation
• Altered DNA Repair, Antioxidant and Cellular Proliferation Status as Determinants of Susceptibility to Methylmercury Toxicity in Vitro

  2014cites this paper
• Common nature in the effects of thalidomide on embryo‐fetal development in Kbl:JW and Kbl:NZW rabbits

  2014cites this paper
• Effects of thalidomide on Fgf8, Bmp4 and Hoxa11 expression in the limb bud in Kbl:JW rabbit embryos

  2014influential citation
• Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.

  2014cites this paper
• Acute Embryotoxicity of Mono-2-Ethylhexyl Phthalate (MEHP) in Mice: Nutrition, Epigenomics, and Environment.

  2014cites this paper
• Organizer formation in Hydra is disrupted by thalidomide treatment.

  2013cites this paper
• Thalidomide-a notorious sedative to a wonder anticancer drug.

  2013cites this paper
• Dissecting the genotype to phenotype relationships of genomic disorders

  2013cites this paper
• Polymorphisms in the endothelial nitric oxide synthase gene in thalidomide embryopathy.

  2013cites this paper
• Redox control of teratogenesis.

  2013cites this paper
• Guidance on classification for reproductive toxicity under the globally harmonized system of classification and labelling of chemicals (GHS)

  2013cites this paper
• Thalidomide Embryopathy: An Enigmatic Challenge

  2013cites this paper
• Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

  2013cites this paper
• Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma

  2013cites this paper
• NF-κB-associated mechanisms underlying the response of embryonic cells to Doxorubicin.

  2013cites this paper
• Deciphering the mystery of thalidomide teratogenicity

  2012cites this paper
• Regulation of Natural Killer Cells: SHIP-1, 2B4, and Immunomodulation by Lenalidomide

  2012cites this paper
• Gene expression analysis in developing embryos: in situ hybridization.

  2012cites this paper
• Microtia: Epidemiology and genetics

  2012cites this paper
• Teratogenic effects of thalidomide: molecular mechanisms

  2011cites this paper
• Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)‐dependent, reactive oxygen species (ROS)‐mediated mechanism

  2011cites this paper
• Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.

  2011influential citation
• Thalidomide: the tragedy of birth defects and the effective treatment of disease.

  2011cites this paper
• Entwicklungsbiologische Grundlagen handchirurgisch relevanter Erkrankungen

  2011cites this paper
• Chapter 31 – Thalidomide

  2011cites this paper
• Identification of a Primary Target of Thalidomide Teratogenicity

  2010cites this paper
• Funktionen der alternsrelevanten Proteine Thioredoxin-1 und Telomerase Reverse Transkriptase in umweltinduzierten Prozessen

  2010cites this paper
• Nuclear Redox Signaling

  2010cites this paper
• Shp-2 als neuer Regulator der Telomerase Reversen Transkriptase im Endothel

  2010cites this paper
• The temporal dynamics of vertebrate limb development, teratogenesis and evolution.

  2010cites this paper
• ORIGINAL ARTICLE: Effect of Maternal Immunopotentiation on Apoptosis‐Associated Molecules Expression in Teratogen‐Treated Embryos

  2009cites this paper
• Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer.

  2009cites this paper
• Sea urchin embryos exposed to thalidomide during early cleavage exhibit abnormal morphogenesis later in development.

  2009cites this paper
• Thalidomide‐induced limb defects: resolving a 50‐year‐old puzzle

  2009cites this paper
• Tumor necrosis factor-alpha-associated mechanisms affecting the embryonic response to cyclophosphamide.

  2009cites this paper
• High-Throughput 3-D Cellular Assays Using Destabilized Green Fluorescence Protein

  2008cites this paper
• Teratogen-induced distortions in the classical NF-kappaB activation pathway: correlation with the ability of embryos to survive teratogenic stress.

  2008cites this paper
• TNFalpha in the pathogenesis of diabetes-induced embryopathies: functions and targets.

  2007cites this paper
• NF-kappaB regulates the response of embryonic cells to heat shock.

  2007cites this paper
• Nucleoredoxin, a Novel Thioredoxin Family Member Involved in Cell Growth and Differentiation

  2007cites this paper
• NF-κB regulates the response of embryonic cells to heat shock

  2007influential citation
• p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding.

  2007cites this paper
• Involvement of NF-κB in the response of embryonic cells to Methotrexate

  2006cites this paper
• Oxidative stress as a mechanism of teratogenesis.

  2006cites this paper
• Involvement of NF-kappaB in the response of embryonic cells to methotrexate.

  2006cites this paper
• Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants.

  2006cites this paper
• Maternal Immunopotentiation Affects Caspase Activation and NF‐κB DNA‐binding Activity in Embryos Responding to an Embryopathic Stress

  2006cites this paper
• Expression of apoptosis-associated molecules in the fetoplacental unit of cyclophosphamide-treated mice.

  2006cites this paper
• Teratogen-induced apoptotic cell death: does the apoptotic machinery act as a protector of embryos exposed to teratogens?

  2005cites this paper
• Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.

  2005cites this paper
• Activator protein-1 (AP-1) DNA binding activity is induced by hydroxyurea in organogenesis stage mouse embryos.

  2005cites this paper
• Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos.

  2005cites this paper
• Antisense Evidence for Nuclear Factor-κB–Dependent Embryopathies Initiated by Phenytoin-Enhanced Oxidative Stress

  2004cites this paper
• Antisense Evidence for Nuclear Factor-κB–Dependent Embryopathies Initiated by Phenytoin-Enhanced Oxidative Stress

  2004cites this paper
• To Die or Not to Die: the Function of the Transcription Factor NF‐κB in Embryos Exposed to Stress

  2004cites this paper
• A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway.

  2004cites this paper
• Response characteristics of the mitochondrial DNA genome in developmental health and disease.

  2004cites this paper
• Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.

  2004cites this paper
• A Novel Hypothesis for Thalidomide-Induced Limb Teratogenesis: Redox Misregulation of the NF-κB Pathway

  2004cites this paper
• New insights into the pharmacological and toxicological effects of thalidomide.

  2003cites this paper
• Thalidomide

  1961cites this paper